Workflow
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
TCMDTactile Systems Technology(TCMD) GlobeNewswire·2025-02-18 21:05

Core Insights - Tactile Systems Technology, Inc. reported strong financial results for Q4 and full year 2024, highlighting a dynamic year with significant product launches and operational improvements [3][4][9]. Financial Performance - Q4 2024 total revenue increased by 7.9million,or107.9 million, or 10%, reaching 85.6 million compared to 77.7millioninQ42023,drivenbyan1177.7 million in Q4 2023, driven by an 11% increase in lymphedema product sales [4][7]. - Gross profit for Q4 2024 rose by 8.4 million, or 15%, to 64.4million,withagrossmarginof75.264.4 million, with a gross margin of 75.2%, up from 72.1% in Q4 2023 [5][7]. - Operating income for Q4 2024 was 12.5 million, compared to 11.8millioninQ42023[6][8].Fullyear2024totalrevenueincreasedby11.8 million in Q4 2023 [6][8]. - Full year 2024 total revenue increased by 18.6 million, or 7%, to 293.0million,withagrossmarginof74293.0 million, with a gross margin of 74%, up from 71% in 2023 [9][10]. Net Income and Earnings - Q4 2024 net income was 9.7 million, or 0.40perdilutedshare,comparedto0.40 per diluted share, compared to 8.2 million, or 0.35perdilutedshare,inQ42023[8][10].Fullyear2024netincomewas0.35 per diluted share, in Q4 2023 [8][10]. - Full year 2024 net income was 17.0 million, or 0.70perdilutedshare,downfrom0.70 per diluted share, down from 28.5 million, or 1.23perdilutedshare,in2023[10].CashFlowandBalanceSheetOperatingcashflowfor2024was1.23 per diluted share, in 2023 [10]. Cash Flow and Balance Sheet - Operating cash flow for 2024 was 40.7 million, compared to 35.9millionin2023,withcashatyearend2024totaling35.9 million in 2023, with cash at year-end 2024 totaling 94.4 million, up from 61.0millionattheendof2023[7][11].Thecompanyended2024with61.0 million at the end of 2023 [7][11]. - The company ended 2024 with 26.3 million in outstanding borrowings, down from 29.3millionin2023[11].StrategicOutlookFor2025,thecompanyexpectstotalrevenuetobeintherangeof29.3 million in 2023 [11]. Strategic Outlook - For 2025, the company expects total revenue to be in the range of 316 million to $322 million, representing growth of approximately 8% to 10% year-over-year [12]. - The company plans to continue investing in enhancing the overall patient experience and expanding treatment options [3].